These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 32909259)

  • 21. GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe.
    Tainta M; Ecay-Torres M; de Arriba M; Barandiaran M; Otaegui-Arrazola A; Iriondo A; Garcia-Sebastian M; Estanga A; Saldias J; Clerigue M; Gabilondo A; Ros N; Mugica J; Barandiaran A; Mangialasche F; Kivipelto M; Arrospide A; Mar J; Martinez-Lage P;
    Alzheimers Res Ther; 2024 Feb; 16(1):44. PubMed ID: 38413990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial.
    Coley N; Zetterberg H; Cantet C; Guyonnet S; Ashton NJ; Vellas B; Blennow K; Andrieu S;
    Lancet Healthy Longev; 2024 Feb; 5(2):e120-e130. PubMed ID: 38310892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of multidomain lifestyle intervention, omega-3 supplementation or their combination on physical activity levels in older adults: secondary analysis of the Multidomain Alzheimer Preventive Trial (MAPT) randomised controlled trial.
    Barreto PS; Rolland Y; Cesari M; Dupuy C; Andrieu S; Vellas B;
    Age Ageing; 2018 Mar; 47(2):281-288. PubMed ID: 29136094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures.
    Sherman DS; Mauser J; Nuno M; Sherzai D
    Neuropsychol Rev; 2017 Dec; 27(4):440-484. PubMed ID: 29282641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce-randomised controlled trial.
    Poppe M; Duffy L; Marchant NL; Barber JA; Hunter R; Bass N; Minihane AM; Walters K; Higgs P; Rapaport P; Lang IA; Morgan-Trimmer S; Huntley J; Walker Z; Brodaty H; Kales HC; Ritchie K; Burton A; Wenborn J; Betz A; Cooper C
    Trials; 2022 Jul; 23(1):596. PubMed ID: 35883143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Remote Intervention to Prevent or Delay Cognitive Impairment in Older Adults: Design, Recruitment, and Baseline Characteristics of the Virtual Cognitive Health (VC Health) Study.
    Bott N; Kumar S; Krebs C; Glenn JM; Madero EN; Juusola JL
    JMIR Res Protoc; 2018 Aug; 7(8):e11368. PubMed ID: 30104186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
    J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial.
    Lautenschlager NT; Cox KL; Flicker L; Foster JK; van Bockxmeer FM; Xiao J; Greenop KR; Almeida OP
    JAMA; 2008 Sep; 300(9):1027-37. PubMed ID: 18768414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
    Solomon A; Turunen H; Ngandu T; Peltonen M; Levälahti E; Helisalmi S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Pajala S; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
    JAMA Neurol; 2018 Apr; 75(4):462-470. PubMed ID: 29356827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol.
    Barbera M; Lehtisalo J; Perera D; Aspö M; Cross M; De Jager Loots CA; Falaschetti E; Friel N; Luchsinger JA; Gavelin HM; Peltonen M; Price G; Neely AS; Thunborg C; Tuomilehto J; Mangialasche F; Middleton L; Ngandu T; Solomon A; Kivipelto M;
    Alzheimers Res Ther; 2024 Jan; 16(1):23. PubMed ID: 38297399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke: Randomized Trial.
    Matz K; Teuschl Y; Firlinger B; Dachenhausen A; Keindl M; Seyfang L; Tuomilehto J; Brainin M;
    Stroke; 2015 Oct; 46(10):2874-80. PubMed ID: 26374482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-Domain Interventions for Dementia Prevention - A Systematic Review.
    Castro CB; Costa LM; Dias CB; Chen J; Hillebrandt H; Gardener SL; Brown BM; Loo RL; Garg ML; Rainey-Smith SR; Martins RN; Sohrabi HR
    J Nutr Health Aging; 2023; 27(12):1271-1280. PubMed ID: 38151879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
    Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
    Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics.
    Pipingas A; Murphy KJ; Davis CR; Itsiopoulos C; Kingsley M; Scholey A; Macpherson H; Segal L; Breckon J; Minihane AM; Meyer D; Ogden E; Dyer KA; Eversteyn E; Hardman RJ; Poorun K; Justice K; Hana M; Buckley JD; White D; Davison K; Clark JS; Bracci EL; Kennedy G;
    J Alzheimers Dis; 2023; 96(1):409-427. PubMed ID: 37781806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's Environmental and Genetic Risk Scores are Differentially Associated With General Cognitive Ability and Dementia Severity.
    Andrews SJ; McFall GP; Dixon RA; Cherbuin N; Eramudugolla R; Anstey KJ
    Alzheimer Dis Assoc Disord; 2019; 33(2):95-103. PubMed ID: 30681434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and evaluation of multidomain attention training to improve alertness attention, sustained attention, and visual-spatial attention in older adults with mild cognitive impairment: A randomized controlled trial.
    Yang HL; Chu H; Kao CC; Miao NF; Chang PC; Tseng P; O'Brien AP; Chou KR
    Int J Geriatr Psychiatry; 2020 May; 35(5):537-546. PubMed ID: 31994767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptation of the Australian National University Alzheimer's Disease Risk Index-Short Form (ANU-ADRI-SF) into Turkish.
    Bayram S; Akkaş ÖA
    Int J Older People Nurs; 2024 Mar; 19(2):e12608. PubMed ID: 38509777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protocol for the Brain Health Support Program Study of the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP): A Prospective 12-Month Intervention Study.
    Feldman HH; Belleville S; Nygaard HB; Montero-Odasso M; Durant J; Lupo JL; Revta C; Chan S; Cuesta M; Slack PJ; Winer S; Brewster PWH; Hofer SM; Lim A; Centen A; Jacobs DM; Anderson ND; Walker JD; Speechley MR; Zou GY; Chertkow H
    J Prev Alzheimers Dis; 2023; 10(4):875-885. PubMed ID: 37874110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.